Medicure Inc. (TSXV:MPH)
Canada · Delayed Price · Currency is CAD 1.350
0.00 (0.00%)
Aug 7, 2026, 3:55 PM EST
Medicure Financials Overview
Financials in millions CAD. Fiscal year is January - December.
Millions CAD. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | - | 28.86 | 21.91 | 21.69 | 23.07 | 21.74 |
Revenue Growth | - | 31.72% | 0.98% | -5.94% | 6.08% | 87.29% |
Gross Profit Gross Profit Growth | 12.43 | 11.75 | 13.09 | 13.99 | 16.08 | 12.71 |
Operating Income Operating Income Growth | -6.6 | -6.89 | -2.74 | -0.85 | 1.19 | -2.09 |
Net Income Net Income Growth | -6.81 | -7.1 | -1.04 | -0.92 | 1.37 | -0.73 |
Earnings Per Share EPS Growth | -0.66 | -0.68 | -0.10 | -0.09 | 0.13 | -0.07 |
EPS Growth | - | - | - | - | - | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 |
|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 |
Retail and Mail Order Pharmacy Retail and Mail Order Pharmacy Growth | 22.74 | 20.29 | 10.83 |
Marketing and Distribution of Commercial Products Marketing and Distribution of Commercial Products Growth | 8.58 | 8.57 | 11.08 |
Total Total Growth | 31.32 | 28.86 | 21.91 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 1.54 | 3.84 | 7.19 | 6.37 | 4.86 | 3.69 |
Total Debt Total Debt Growth | 0.8 | 0.89 | 0.87 | 0.54 | 0.85 | 1.17 |
Net Cash (Debt) Net Cash Growth | 0.74 | 2.94 | 6.32 | 5.83 | 4.01 | 2.53 |
Net Cash Growth | -88.34% | -53.40% | 8.45% | 45.33% | 58.73% | 98.98% |
Net Cash Per Share Net Cash Per Share Growth | 0.07 | 0.28 | 0.61 | 0.56 | 0.38 | 0.25 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | -3.04 | -0.56 | 1.38 | 2.08 | 1.83 | 3.99 |
Capital Expenditures CapEx Growth | - | - | - | - | -0.01 | -0.38 |
Free Cash Flow Free Cash Flow Growth | -3.04 | -0.56 | 1.38 | 2.08 | 1.81 | 3.61 |
Free Cash Flow Growth | - | - | -33.77% | 14.61% | -49.78% | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | - | 40.71% | 59.75% | 64.48% | 69.69% | 58.46% |
Operating Margin | - | -23.87% | -12.49% | -3.94% | 5.17% | -9.63% |
Pretax Margin | - | -23.87% | -3.57% | -4.13% | 6.00% | -3.49% |
Profit Margin | - | -23.15% | -2.41% | -4.02% | 6.09% | -3.64% |
FCF Margin | - | -1.94% | 6.29% | 9.58% | 7.86% | 16.61% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 11, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | - | - | - | - | 7.72 | - |
Forward PE | - | 11.48 | 11.48 | 11.48 | 11.48 | 11.48 |
P/FCF Ratio | - | - | 6.67 | 7.03 | 5.71 | 2.61 |
PS Ratio | 0.45 | 0.41 | 0.42 | 0.67 | 0.45 | 0.43 |